首页> 美国卫生研究院文献>Journal of Clinical Oncology >Phase III Randomized Study of Rituximab/Carmustine Etoposide Cytarabine and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT CTN 0401 Trial

【2h】

Phase III Randomized Study of Rituximab/Carmustine Etoposide Cytarabine and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT CTN 0401 Trial

机译：利妥昔单抗/卡莫司汀依托泊苷阿糖胞苷和美法仑（BEAM）与碘131 Tositumomab / BEAM与自体造血细胞移植治疗复发性弥漫性大B细胞淋巴瘤的III期随机研究：来自BMT CTN 0401试验的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

PurposeThis clinical trial evaluated standard-dose radioimmunotherapy with a chemotherapy-based transplantation regimen followed by autologous hematopoietic cell transplantation versus rituximab with the same regimen in patients with relapsed diffuse large B-cell lymphoma (DLBCL).

机译：目的这项临床试验评估了复发性弥漫性大B细胞淋巴瘤（DLBCL）患者采用基于化学疗法的移植方案，然后采用自体造血细胞移植与利妥昔单抗采用相同方案的标准剂量放射免疫疗法。

著录项

期刊名称 Journal of Clinical Oncology
作者
Julie M. Vose; Shelly Carter; Linda J. Burns; Ernesto Ayala; Oliver W. Press; Craig H. Moskowitz; Edward A. Stadtmauer; Shin Mineshi; Richard Ambinder; Timothy Fenske; Mary Horowitz; Richard Fisher; Marcie Tomblyn;
展开▼
作者单位

展开▼
年(卷),期 -1(31),13
年度 -1
页码 1662–1668
总页数 8
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献

1. Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT CTN 0401 Trial. [J] . Julie M Vose, Shelly Carter, Linda J Burns, Journal of Clinical Oncology . 2013,第13期

机译：利妥昔单抗/卡莫司汀，依托泊苷，阿糖胞苷和美法仑（BEAM）与碘131托西单抗/ BEAM与自体造血细胞移植治疗复发性弥漫性大B细胞淋巴瘤的III期随机研究：来自BMT CTN 0401试验的结果。
2. Outcomes of BeEAM (bendamustine, etoposide, cytarabine, melphalan) Compared to BEAM (carmustine, etoposide, cytarabine, melphalan) for High Dose Chemotherapy Followed By Autologous Stem Cell Transplant [J] . Cameron Ninos, Jason Jared, Mary Mably, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：与高剂量化疗的梁（Carmustine，eToposide，Cytarabine，Melphalan）进行了与高剂量化疗的展示（弯曲蛋白蛋白，胸蛋白，糖醇，梅尔甜菜）的结果，然后是自体干细胞移植
3. Outcomes of BeEAM (bendamustine, etoposide, cytarabine, melphalan) Compared to BEAM (carmustine, etoposide, cytarabine, melphalan) for High Dose Chemotherapy Followed By Autologous Stem Cell Transplant [J] . Cameron Ninos, Jason Jared, Mary Mably, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：None
4. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
5. Comparable safety profile of BeEAM (bendamustine etoposide cytarabine melphalan) and BEAM (carmustine etoposide cytarabine melphalan) as conditioning before autologous haematopoietic cell transplantation [O] . Andrzej Frankiewicz, Maria Saduś-Wojciechowska, Jacek Najda, 2018

机译：作为自体造血细胞移植前条件的BeEAM（苯达莫司汀依托泊苷阿糖胞苷美法仑）和BEAM（卡莫司汀依托泊苷阿糖胞苷美法仑）的可比性安全性
6. Matched Pair Comparison of Busulfan/Cyclophosphamide/Etoposide (BuCyE) to Carmustine/Etoposide/Cytarabine/Melphalan (BEAM) Conditioning Regimen Prior to Autologous Hematopoietic Cell Transplantation (autoHCT) for Lymphoma [O] . CIBMTR, CIBMTR/Medical College of Wisconsin, Milwaukee, WI ( host institution ), Pasquini, Marcelo C. ( author ), Le Rademacher, Jennifer ( author ), 2014

机译：自体造血细胞移植（autoHCT）之前，将白消安/环磷酰胺/依托泊苷（BuCyE）与卡马汀/依托泊苷/阿糖胞苷/美法仑（BEAM）调理方案的配对配对比较

Phase III Randomized Study of Rituximab/Carmustine Etoposide Cytarabine and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT CTN 0401 Trial

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅